Literature DB >> 30145001

Decision making for the central compartment in differentiated thyroid cancer.

João Gonçalves Filho1, Mark E Zafereo2, Faisal I Ahmad3, Iain J Nixon4, Ashok R Shaha5, Vincent Vander Poorten6, Alvaro Sanabria7, Avi Khafif Hefetz8, K Thomas Robbins9, Dipti Kamani10, Gregory W Randolph10, Andres Coca-Pelaz11, Ricard Simo12, Alessandra Rinaldo13, Peter Angelos14, Alfio Ferlito15, Luiz P Kowalski1.   

Abstract

The central compartment is a common site for nodal spread from differentiated thyroid carcinoma, often occurring in patients without clinical or ultrasonographic (US) evidence of neck lymph node metastasis (cN0). However, the role of elective central compartment neck dissection (CND) among patients with DTC remains controversial. We performed a systematic literature review, also including review of international guidelines, with discussion of anatomic and technical aspects, as well as risks and benefits of performing elective CND. The recent literature does not uniformly support or refute elective CND in patients with DTC, and therefore an individualized approach is warranted which considers individual surgeon experience, including individual recurrence and complication rates. Patients (especially older males) with large tumors (>4 cm) and extrathyroidal extension are more likely to benefit from elective CND, but elective CND also increases risk for hypoparathyroidism and recurrent nerve injury, especially when operated by low-volume surgeons. Individual surgeons who perform elective CND must ensure the number of central compartment dissections needed to prevent one recurrence (number needed to treat) is not disproportionate to their individual number of central compartment dissections per related complication (number needed to harm). Published by Elsevier Ltd.

Entities:  

Keywords:  Central compartment; Level VI; Lymph node metastases; Neck dissection; Surgery; Thyroid cancer; Thyroidectomy

Mesh:

Year:  2018        PMID: 30145001     DOI: 10.1016/j.ejso.2018.08.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

Review 1.  Revision Thyroid Surgery.

Authors:  Karthik Nagaraja Rao; Satish Satpute; Nitin M Nagarkar; Ambesh Singh
Journal:  Indian J Surg Oncol       Date:  2021-11-04

2.  Ultrasound-guided thermal ablation for cervical lymph node metastasis from thyroid carcinoma: a meta-analysis of clinical efficacy and safety.

Authors:  Yuxuan Qiu; Zhichao Xing; Yushuang He; Jingyan Liu; Qianru Yang; Yan Luo
Journal:  Lasers Med Sci       Date:  2021-10-06       Impact factor: 3.161

3.  The predictive factors for postoperative hypoparathyroidism and its severity on the first postoperative day after papillary thyroid carcinoma surgery.

Authors:  Renhong Huang; Qiang Wang; Wei Zhang; Siluo Zha; Daozhen Jiang; Xinyun Xu; Xiangmin Zheng; Ming Qiu; Chengxiang Shan
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-20       Impact factor: 2.503

4.  Magnetic resonance imaging (MRI) radiomics of papillary thyroid cancer (PTC): a comparison of predictive performance of multiple classifiers modeling to identify cervical lymph node metastases before surgery.

Authors:  Hui Qin; Qiao Que; Peng Lin; Xin Li; Xin-Rong Wang; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Radiol Med       Date:  2021-07-08       Impact factor: 3.469

5.  U-shaped strap muscle flap for difficult thyroid surgery.

Authors:  How-Yun Ko; I-Cheng Lu; Pi-Ying Chang; Ling-Feng Wang; Che-Wei Wu; Wing-Hei Viola Yu; Tzer Zen Hwang; Chien Chung Wang; Tzu-Yen Huang; Feng-Yu Chiang
Journal:  Gland Surg       Date:  2020-04

6.  High rate of IIA/IIB neck groups involvement supports complete lateral neck dissection in thyroid carcinoma.

Authors:  Emilien Chebib; Caroline Eymerit; Nathalie Chabbert-Buffet; Bruno Angelard; Jean Lacau St Guily; Sophie Périé
Journal:  Gland Surg       Date:  2020-12

7.  Thyroid Surgery: Whose Domain Is It?

Authors:  Peter Zbären; Jatin P Shah; Gregory W Randolph; Carl E Silver; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Luiz P Kowalski; Carlos Suarez; Alvaro Sanabria; Vincent Vander Poorten; Iain Nixon; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2019-08-10       Impact factor: 3.845

8.  Do carbon nanoparticles really improve thyroid cancer surgery? A retrospective analysis of real-world data.

Authors:  Junsong Liu; Chongwen Xu; Rui Wang; Peng Han; Qian Zhao; Honghui Li; Yanxia Bai; Lifeng Liu; Shaoqiang Zhang; Xiaobao Yao
Journal:  World J Surg Oncol       Date:  2020-05-02       Impact factor: 2.754

9.  Real-World Evidence on the Sensitivity of Preoperative Ultrasound in Evaluating Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Authors:  Fan Yao; Zhongyuan Yang; Yixuan Li; Weichao Chen; Tong Wu; Jin Peng; Zan Jiao; Ankui Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.